Fatemeh Esfahanian

533 total citations
31 papers, 365 citations indexed

About

Fatemeh Esfahanian is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Neurology. According to data from OpenAlex, Fatemeh Esfahanian has authored 31 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 3 papers in Neurology. Recurrent topics in Fatemeh Esfahanian's work include Pituitary Gland Disorders and Treatments (8 papers), Adrenal and Paraganglionic Tumors (5 papers) and Thyroid Disorders and Treatments (5 papers). Fatemeh Esfahanian is often cited by papers focused on Pituitary Gland Disorders and Treatments (8 papers), Adrenal and Paraganglionic Tumors (5 papers) and Thyroid Disorders and Treatments (5 papers). Fatemeh Esfahanian collaborates with scholars based in Iran, Canada and France. Fatemeh Esfahanian's co-authors include Reza Tavakkoli‐Moghaddam, Mohammad Mehdi Sepehri, Amir Azaron, Zohreh Jadali, Alireza Esteghamati, Manouchehr Nakhjavani, Armin Rashidi, Alipasha Meysamie, Omid Khalilzadeh and Atieh Amouzegar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and European Journal of Clinical Nutrition.

In The Last Decade

Fatemeh Esfahanian

28 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatemeh Esfahanian Iran 13 165 61 49 45 42 31 365
Anja Schiel Norway 13 99 0.6× 41 0.7× 25 0.5× 19 0.4× 150 3.6× 24 582
Fumiko Satoh Japan 15 48 0.3× 67 1.1× 66 1.3× 37 0.8× 122 2.9× 52 572
Ryan G. Short United States 13 148 0.9× 127 2.1× 51 1.0× 29 0.6× 68 1.6× 24 693
Marco Migliardi Italy 15 173 1.0× 83 1.4× 27 0.6× 36 0.8× 47 1.1× 40 576
Arjen‐Kars Boer Netherlands 11 37 0.2× 103 1.7× 48 1.0× 49 1.1× 39 0.9× 36 367
Wenhui Huang China 12 73 0.4× 60 1.0× 67 1.4× 17 0.4× 40 1.0× 37 455
Qingyan Huang China 12 27 0.2× 60 1.0× 44 0.9× 33 0.7× 137 3.3× 35 375
Egil Henriksen Sweden 16 54 0.3× 107 1.8× 39 0.8× 23 0.5× 91 2.2× 35 735
Kenji Hoshi Japan 11 30 0.2× 67 1.1× 49 1.0× 28 0.6× 117 2.8× 40 356
W. Oberaigner Austria 10 70 0.4× 35 0.6× 72 1.5× 70 1.6× 42 1.0× 18 325

Countries citing papers authored by Fatemeh Esfahanian

Since Specialization
Citations

This map shows the geographic impact of Fatemeh Esfahanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatemeh Esfahanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatemeh Esfahanian more than expected).

Fields of papers citing papers by Fatemeh Esfahanian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatemeh Esfahanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatemeh Esfahanian. The network helps show where Fatemeh Esfahanian may publish in the future.

Co-authorship network of co-authors of Fatemeh Esfahanian

This figure shows the co-authorship network connecting the top 25 collaborators of Fatemeh Esfahanian. A scholar is included among the top collaborators of Fatemeh Esfahanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatemeh Esfahanian. Fatemeh Esfahanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Esfahanian, Fatemeh, et al.. (2025). Pheochromocytoma in a patient with heterotaxy syndrome: a case report. BMC Endocrine Disorders. 25(1). 65–65.
2.
Tavakkoli‐Moghaddam, Reza, et al.. (2022). Prioritizing the glucose-lowering medicines for type 2 diabetes by an extended fuzzy decision-making approach with target-based attributes. Medical & Biological Engineering & Computing. 60(8). 2423–2444. 7 indexed citations
3.
Esfahanian, Fatemeh, SeyedAhmad SeyedAlinaghi, Nazanin Janfaza, & Marcarious M. Tantuoyir. (2021). Predictors of hospital mortality among patients with COVID-19 in Tehran, Iran. SHILAP Revista de lepidopterología. 9. 3901902389–3901902389. 9 indexed citations
4.
Esfahanian, Fatemeh, et al.. (2021). Increased Mitochondrial DNA Copy Number and Oxidative Damage in Patients with Hashimoto’s Thyroiditis. Iranian Journal of Public Health. 50(8). 1697–1704. 5 indexed citations
5.
Esfahanian, Fatemeh, et al.. (2021). IgG4-related hypophysitis. Endocrine. 73(2). 270–291. 16 indexed citations
6.
Tavakkoli‐Moghaddam, Reza, et al.. (2019). A Markov decision process for modeling adverse drug reactions in medication treatment of type 2 diabetes. Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine. 233(8). 793–811. 14 indexed citations
7.
Esfahanian, Fatemeh, et al.. (2019). Surgical Outcome of Endoscopic Endonasal Surgery of Large and Giant Pituitary Adenomas: An Institutional Experience from the Middle East. World Neurosurgery. 132. e802–e811. 27 indexed citations
8.
Tavakkoli‐Moghaddam, Reza, et al.. (2018). Pharmacological therapy selection of type 2 diabetes based on the SWARA and modified MULTIMOORA methods under a fuzzy environment. Artificial Intelligence in Medicine. 87. 20–33. 44 indexed citations
9.
Jadali, Zohreh, et al.. (2017). Increased levels of serum interleukin-17 in patients with Hashimoto's thyroiditis. Indian Journal of Endocrinology and Metabolism. 21(4). 551–551. 25 indexed citations
10.
Esfahanian, Fatemeh, et al.. (2012). Cushing's Syndrome during Pregnancy: Post Delivery Adrenalectomy Consequent to Medical Management without Adrenal Enzyme Inhibitors. Galen Medical Journal. 1(1). 38–41. 1 indexed citations
11.
12.
Esfahanian, Fatemeh, et al.. (2011). Overnight dexamethasone suppression test in the diagnosis of Cushing's disease.. PubMed. 48(4). 222–5. 4 indexed citations
13.
Nakhjavani, Manouchehr, Afsaneh Morteza, Alipasha Meysamie, et al.. (2010). Serum heat shock protein 70 and oxidized LDL in patients with type 2 diabetes: does sex matter?. Cell Stress and Chaperones. 16(2). 195–201. 26 indexed citations
14.
Azizi, Fereidoun, et al.. (2008). Outbreak of exogenous Cushing's syndrome due to unlicensed medications. Clinical Endocrinology. 69(6). 921–925. 13 indexed citations
15.
Nakhjavani, Manouchehr, et al.. (2008). HbA1c negatively correlates with LCAT activity in type 2 diabetes. Diabetes Research and Clinical Practice. 81(1). 38–41. 22 indexed citations
16.
Nakhjavani, Manouchehr, Alireza Esteghamati, Fatemeh Esfahanian, et al.. (2008). Albuminuria and its correlates in an Iranian type 2 diabetic population. Lipids in Health and Disease. 7(1). 28–28. 6 indexed citations
17.
Esfahanian, Fatemeh, et al.. (2007). LECITHIN: CHOLESTEROL ACYLTRANSFERASE ACTIVITY IS DECREASED IN TYPE 2 DIABETES MELLITUS. ACTA MEDICA IRANICA. 45(6). 481–486. 3 indexed citations
18.
Hamidi, Sepehr, et al.. (2007). Distribution of solitary parathyroid adenoma over the parathyroid glands and its surgical management.. PubMed. 17(10). 619–21. 1 indexed citations
19.
Jadali, Zohreh, et al.. (2005). Hepatitis C Virus Antibodies and Vitiligo Disease. SHILAP Revista de lepidopterología. 34(1). 23–26. 8 indexed citations
20.
Ghaeli, Padideh, et al.. (2003). Risk factors of thyroid abnormalities in bipolar patients receiving lithium: a case control study. BMC Psychiatry. 3(1). 4–4. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anja Schiel Breakdown of academic impact, for papers by Fumiko Satoh Breakdown of academic impact, for papers by Ryan G. Short Breakdown of academic impact, for papers by Marco Migliardi Breakdown of academic impact, for papers by Arjen‐Kars Boer Breakdown of academic impact, for papers by Wenhui Huang Breakdown of academic impact, for papers by Qingyan Huang Breakdown of academic impact, for papers by Egil Henriksen Breakdown of academic impact, for papers by Kenji Hoshi Breakdown of academic impact, for papers by W. Oberaigner
Rankless by CCL
2026